Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 13 | 17,149 | $923K |
| Grant or award | 14 | 78,043 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
64 Form 4 filings on record, the earliest from Oct 7, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jing L. Marantz - Officer | Option exercise | Common Stock | 109,375 | $8.59 | $940K | |
| Jing L. Marantz - Officer | Open-market sale | Common Stock | 67,448 | $25.59 | $1.73M | |
| Jing L. Marantz - Officer | Open-market sale | Common Stock | 2,552 | $26.22 | $67K | |
| Jing L. Marantz - Officer | Open-market sale | Common Stock | 39,375 | $30.06 | $1.18M | |
| Jing L. Marantz - Officer | Option exercise | Stock Option (Right to Buy) | 109,375 | $0.00 | - | |
| Tracey Sacco - Officer | Option exercise | Common Stock | 30,000 | $10.00 | $300K | |
| Tracey Sacco - Officer | Open-market sale | Common Stock | 28,036 | $25.58 | $717K | |
| Tracey Sacco - Officer | Open-market sale | Common Stock | 1,964 | $26.23 | $52K | |
| Tracey Sacco - Officer | Option exercise | Stock Option (Right to Buy) | 30,000 | $0.00 | - | |
| Open-market sale | Common Stock | 510,000 | $27.50 | $14.03M | ||
| Open-market sale | Common Stock | 510,000 | $30.00 | $15.30M | ||
| Open-market sale | Common Stock | 155,713 | $32.50 | $5.06M | ||
| Edward H. Myles - Officer | Option exercise | Common Stock | 206,240 | $13.83 | $2.85M | |
| Edward H. Myles - Officer | Open-market sale | Common Stock | 111,972 | $25.61 | $2.87M | |
| Edward H. Myles - Officer | Open-market sale | Common Stock | 37,206 | $26.83 | $998K | |
| Edward H. Myles - Officer | Open-market sale | Common Stock | 25,812 | $27.27 | $704K | |
| Edward H. Myles - Officer | Open-market sale | Common Stock | 31,250 | $29.05 | $908K | |
| Edward H. Myles - Officer | Option exercise | Stock Option (Right to Buy) | 165,810 | $0.00 | - |
This is as far as the anonymous view goes. Create a free account for all 64 SRRK filings on record.
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
Scholar Rock Holding Corp (SRRK) had 12 insider filings in the last 90 days, with the most recent on 2026-07-06. The full record for SRRK runs to 64 Form 4 filings, the earliest from 2024-10-07. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of SRRK were filed in the last 90 days. 9 purchases are on record for this company.
13 insider sales of SRRK were filed in the last 90 days, totaling $923K.
This page tracks SRRK Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add SRRK to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.